Year |
Citation |
Score |
2024 |
Song X, Tiek D, Miki S, Huang T, Lu M, Goenka A, Iglesia RP, Yu X, Wu R, Walker MN, Zeng C, Shah H, Weng SHS, Huff A, Zhang W, ... ... Hubert CG, et al. RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma. The Journal of Clinical Investigation. PMID 38662454 DOI: 10.1172/JCI173789 |
0.361 |
|
2023 |
Verduin M, Hoosemans L, Vanmechelen M, van Heumen M, Piepers JAF, Astuti G, Ackermans L, Schijns OEMG, Kampen KR, Tjan-Heijnen VCG, de Barbanson BA, Postma AA, Eekers DBP, Broen MPG, Beckervordersandforth J, ... ... Hubert CG, et al. Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neuro-Oncology Advances. 5: vdad152. PMID 38130902 DOI: 10.1093/noajnl/vdad152 |
0.333 |
|
2023 |
Hubert CG, Stauffer SR, Lathia JD. A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer. Plos Biology. 21: e3002295. PMID 37713380 DOI: 10.1371/journal.pbio.3002295 |
0.436 |
|
2023 |
Mitchell K, Sprowls SA, Arora S, Shakya S, Silver DJ, Goins CM, Wallace L, Roversi G, Schafer R, Kay K, Miller TE, Lauko A, Bassett J, Kashyap A, D'Amato Kass J, ... ... Hubert CG, et al. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma. Genes & Development. PMID 36732025 DOI: 10.1101/gad.349803.122 |
0.465 |
|
2022 |
Sundar SJ, Shakya S, Recinos V, Hubert CG. Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture. Journal of Visualized Experiments : Jove. PMID 36094291 DOI: 10.3791/63745 |
0.369 |
|
2022 |
Shields JA, Meier SR, Bandi M, Mulkearns-Hubert EE, Hajdari N, Dam Ferdinez M, Engel JL, Silver DJ, Shen B, Zhang W, Hubert CG, Mitchell K, Shakya S, Zhao SC, Bejnood A, et al. VRK1 is a Synthetic Lethal Target in VRK2-deficient Glioblastoma. Cancer Research. PMID 36069976 DOI: 10.1158/0008-5472.CAN-21-4443 |
0.384 |
|
2022 |
Hubert CG, Rich JN. Patient-derived explants as tumor models. Cancer Cell. 40: 348-350. PMID 35364017 DOI: 10.1016/j.ccell.2022.03.004 |
0.382 |
|
2021 |
Knudsen AM, Halle B, Cédile O, Burton M, Baun C, Thisgaard H, Anand A, Hubert C, Thomassen M, Michaelsen SR, Olsen BB, Dahlrot RH, Bjerkvig R, Lathia JD, Kristensen BW. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro-Oncology. PMID 34964899 DOI: 10.1093/neuonc/noab302 |
0.327 |
|
2021 |
Sundar SJ, Shakya S, Barnett A, Wallace LC, Jeon H, Sloan A, Recinos V, Hubert CG. Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma. Translational Oncology. 15: 101251. PMID 34700192 DOI: 10.1016/j.tranon.2021.101251 |
0.325 |
|
2021 |
Shakya S, Gromovsky AD, Hale JS, Knudsen AM, Prager B, Wallace LC, Penalva LOF, Brown HA, Kristensen BW, Rich JN, Lathia JD, Brown JM, Hubert CG. Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches. Acta Neuropathologica Communications. 9: 101. PMID 34059134 DOI: 10.1186/s40478-021-01205-7 |
0.363 |
|
2020 |
Prager BC, Bhargava S, Mahadev V, Hubert CG, Rich JN. Glioblastoma Stem Cells: Driving Resilience through Chaos. Trends in Cancer. 6: 223-235. PMID 32101725 DOI: 10.1016/j.trecan.2020.01.009 |
0.398 |
|
2019 |
Wallace L, Gromovsky A, Hale J, Knudsen A, Prager B, Silver D, Sloan A, Kristensen B, Lathia J, Mark Brown J, Rich J, Hubert C. STEM-26. ALTERED LIPID METABOLISM MARKS GLIOBLASTOMA STEM AND NON-STEM CELLS IN SEPARATE TUMOR NICHES Neuro-Oncology. 21: vi239-vi239. DOI: 10.1093/neuonc/noz175.999 |
0.402 |
|
2018 |
Yi C, Li G, Ivanov DN, Wang Z, Velasco M, Hernandez G, Kaundal S, Villarreal J, Gupta YK, Qiao M, Hubert CG, Hart MJ, Penalva LOF. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. Rna Biology. PMID 30362859 DOI: 10.1080/15476286.2018.1539607 |
0.482 |
|
2018 |
Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, et al. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell. 22: 514-528.e5. PMID 29625067 DOI: 10.1016/J.Stem.2018.03.011 |
0.504 |
|
2017 |
Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow JJ, Saiakhova A, Sin-Chan P, ... ... Hubert CG, et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature. PMID 29258295 DOI: 10.1038/Nature25169 |
0.335 |
|
2017 |
Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC, Fernandez E, Richner JM, Zhang R, Shan C, Tycksen E, Wang X, Shi PY, Diamond MS, Rich JN, et al. Correction: Zika virus has oncolytic activity against glioblastoma stem cells. The Journal of Experimental Medicine. PMID 28916645 DOI: 10.1084/Jem.2017109309122017C |
0.365 |
|
2017 |
Zhu Z, Gorman MJ, McKenzie LD, Chai JN, Hubert CG, Prager BC, Fernandez E, Richner JM, Zhang R, Shan C, Wang X, Shi PY, Diamond MS, Rich JN, Chheda MG. Zika virus has oncolytic activity against glioblastoma stem cells. The Journal of Experimental Medicine. PMID 28874392 DOI: 10.1084/Jem.20171093 |
0.425 |
|
2017 |
Wang X, Huang Z, Wu Q, Prager BC, Mack SC, Yang K, Kim LJY, Gimple RC, Shi Y, Lai S, Xie Q, Miller TE, Hubert CG, Song A, Dong Z, et al. MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells. Cancer Research. PMID 28729418 DOI: 10.1158/0008-5472.Can-17-0114 |
0.457 |
|
2017 |
Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, Factor DC, Kim LJY, Morrow JJ, Wu Q, Mack SC, Hubert CG, Gillespie SM, Flavahan WA, Hoffmann T, et al. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature. PMID 28678782 DOI: 10.1038/Nature23000 |
0.379 |
|
2017 |
Marcelino Meliso F, Hubert CG, Favoretto Galante PA, Penalva LO. RNA processing as an alternative route to attack glioblastoma. Human Genetics. PMID 28608251 DOI: 10.1007/s00439-017-1819-2 |
0.437 |
|
2017 |
Jung J, Kim LJY, Wang X, Wu Q, Sanvoranart T, Hubert CG, Prager BC, Wallace LC, Jin X, Mack SC, Rich JN. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. Jci Insight. 2. PMID 28515364 DOI: 10.1172/jci.insight.90019 |
0.379 |
|
2017 |
Wang X, Yang K, Xie Q, Wu Q, Mack SC, Shi Y, Kim LJ, Prager BC, Flavahan WA, Liu X, Singer M, Hubert CG, Miller TE, Zhou W, Huang Z, et al. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma. Nature Neuroscience. PMID 28346452 DOI: 10.1038/Nn.4537 |
0.475 |
|
2017 |
Ayuso JM, Monge R, Martínez-González A, Virumbrales-Muñoz M, Llamazares GA, Berganzo J, Hernández-Laín A, Santolaria J, Doblaré M, Hubert C, Rich JN, Sánchez-Gómez P, Pérez-García VM, Ochoa I, Fernández LJ. Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncology. PMID 28062831 DOI: 10.1093/Neuonc/Now230 |
0.31 |
|
2017 |
Miller TE, Liau B, Wallace LC, Morton A, Xie Q, Dixit D, Factor D, Kim L, Morrow J, Wu Q, Mack S, Hubert C, Paddison PJ, Horbinski C, Bernstein B, et al. GENE-30. TRANSCRIPTION ELONGATION FACTORS REPRESENT IN VIVO CANCER DEPENDENCIES IN GLIOBLASTOMA Neuro-Oncology. 19: vi99-vi99. DOI: 10.1093/Neuonc/Nox168.404 |
0.355 |
|
2017 |
Hubert C, Rivera M, Wallace LC, Wu Q, Mack S, Prager B, Miller TE, Couce M, McLendon R, Sloan A, Rich J. TMOD-16. MODELING GLIOBLASTOMA THROUGH CANCER STEM CELL ORGANOIDS Neuro-Oncology. 19: vi257-vi257. DOI: 10.1093/Neuonc/Nox168.1054 |
0.457 |
|
2016 |
Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, Couce M, McLendon RE, Sloan AE, Rich JN. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Research. PMID 26896279 DOI: 10.1158/0008-5472.Can-15-2402 |
0.499 |
|
2015 |
Mack SC, Hubert CG, Miller TE, Taylor MD, Rich JN. An epigenetic gateway to brain tumor cell identity. Nature Neuroscience. 19: 10-9. PMID 26713744 DOI: 10.1038/nn.4190 |
0.461 |
|
2015 |
Hitomi M, Deleyrolle LP, Mulkearns-Hubert EE, Jarrar A, Li M, Sinyuk M, Otvos B, Brunet S, Flavahan WA, Hubert CG, Goan W, Hale JS, Alvarado AG, Zhang A, Rohaus M, et al. Differential connexin function enhances self-renewal in glioblastoma. Cell Reports. 11: 1031-42. PMID 25959821 DOI: 10.1016/J.Celrep.2015.04.021 |
0.375 |
|
2015 |
Xie Q, Wu Q, Mack SC, Yang K, Kim L, Hubert CG, Flavahan WA, Chu C, Bao S, Rich JN. CDC20 maintains tumor initiating cells. Oncotarget. 6: 13241-54. PMID 25938542 DOI: 10.18632/Oncotarget.3676 |
0.486 |
|
2015 |
Adorno-Cruz V, Kibria G, Liu X, Doherty M, Junk DJ, Guan D, Hubert C, Venere M, Mulkearns-Hubert E, Sinyuk M, Alvarado A, Caplan AI, Rich J, Gerson SL, Lathia J, et al. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Research. 75: 924-9. PMID 25604264 DOI: 10.1158/0008-5472.Can-14-3225 |
0.451 |
|
2013 |
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P, Hardcastle J, Basom R, Delrow JJ, Webb T, Pollard SM, et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes & Development. 27: 1032-45. PMID 23651857 DOI: 10.1101/Gad.212548.112 |
0.644 |
|
2013 |
Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK, Pollard SM, Nam DH, Delrow JJ, Zhu J, Lee J, et al. Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells. Cancer Discovery. 3: 198-211. PMID 23154965 DOI: 10.1158/2159-8290.Cd-12-0353 |
0.647 |
|
2013 |
Hubert CG, Bradley RK, Ding Y, Chad TM, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P, Basom R, Delrow JJ, Webb T, Pollard SM, Lee J, Olson JM, et al. Abstract A20: Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A20 |
0.652 |
|
2013 |
Ding Y, Hubert C, Herman J, DeLuca J, Olson J, Paddison P. Abstract A05: Functional genetic approach identifies cancer-specific requirement for BUB1B/BubR1 in human brain tumor isolates and genetically transformed cells Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A05 |
0.652 |
|
2012 |
Hubert CG, Ding Y, Toledo C, Paddison PJ, Olson JM, Berndt J. Abstract 5118: A functional genetic approach in patient-derived glioblastoma stem cells reveals pre-mRNA splicing components to be cancer-lethal gene targets Cancer Research. 72: 5118-5118. DOI: 10.1158/1538-7445.Am2012-5118 |
0.65 |
|
2012 |
Leonard A, Wolff J, Sengupta R, Marassa J, Piwnica-Worms D, Rubin J, Pollack I, Jakacki R, Butterfield L, Okada H, Fangusaro J, Warren KE, Mullins C, Jurgen P, Julia S, ... ... Hubert C, et al. HIGH GRADE GLIOMAS Neuro-Oncology. 14: i56-i68. DOI: 10.1093/Neuonc/Nos102 |
0.381 |
|
Show low-probability matches. |